(Q37206232)

18 August 2017

1 reference

title

Comparison of the Abbott Realtime HIV-1 and HCV viral load assays with commercial competitor assays (English)

1 reference

18 August 2017

1 reference

1

Martin Schutten

1 reference

18 August 2017

1 July 2008

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

18 August 2017

1 reference

18 August 2017

8

1 reference

18 August 2017

4

1 reference

18 August 2017

369-377

1 reference

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

18 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

Management and treatment of hepatitis C viral infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center program and the National Hepatitis C Program office

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

Nucleic acid sequence-based amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

Single rapid real-time monitored isothermal RNA amplification assay for quantification of human immunodeficiency virus type 1 isolates from groups M, N, and O

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

Avoiding false positives with PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

Multicenter Evaluation of the New Abbott RealTime Assays for Quantitative Detection of Human Immunodeficiency Virus Type 1 and Hepatitis C Virus RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

Clinical utility of viral quantification as a tool for disease monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

Automated extraction of viral-pathogen RNA and DNA for high-throughput quantitative real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

Comparison of Performance Characteristics of Three Real-Time Reverse Transcription-PCR Test Systems for Detection and Quantification of Hepatitis C Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

Comparison of the Abbott 7000 and Bayer 340 Systems for Measurement of Hepatitis C Virus Load

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

Improved COBAS TaqMan Hepatitis C Virus Test (Version 2.0) for Use with the High Pure System: Enhanced Genotype Inclusivity and Performance Characteristics in a Multisite Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

Partially double-stranded linear DNA probes: novel design for sensitive detection of genetically polymorphic targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

Thermodynamically modulated partially double-stranded linear DNA probe design for homogeneous real-time PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

Drift in the hypervariable region of the hepatitis C virus during 27 years in two patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

Performance of the automated Abbott RealTime HIV-1 assay on a genetically diverse panel of specimens from Brazil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

Performance of the automated Abbott RealTime HIV-1 assay on a genetically diverse panel of specimens from London: comparison to VERSANT HIV-1 RNA 3.0, AMPLICOR HIV-1 MONITOR v1.5, and LCx HIV RNA Quantitative assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

Evaluation of performance across the dynamic range of the Abbott RealTime HIV-1 assay as compared to VERSANT HIV-1 RNA 3.0 and AMPLICOR HIV-1 MONITOR v1.5 using serial dilutions of 39 group M and O viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

Comparative evaluation of the performance of the Abbott real-time human immunodeficiency virus type 1 (HIV-1) assay for measurement of HIV-1 plasma viral load following automated specimen preparation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

Evaluation of the Abbott RealTime HCV assay for quantitative detection of hepatitis C virus RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

Evaluation of the analytical performance of the new Abbott RealTime RT-PCRs for the quantitative detection of HCV and HIV-1 RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

Impact of Hepatitis C Virus (HCV) Genotypes on Quantification of HCV RNA in Serum by COBAS AmpliPrep/COBAS TaqMan HCV Test, Abbott Antiretroviral Therapy HCV RealTime Assay, and VERSANT HCV RNA Assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

Comparison of the Roche COBAS Amplicor Monitor, Roche COBAS Ampliprep/COBAS Taqman and Abbott RealTime Test assays for quantification of hepatitis C virus and HIV RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

Frequency of very low HCV viremia detected by a highly sensitive HCV-RNA assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

A novel internally controlled real-time reverse transcription-PCR assay for HIV-1 RNA targeting the pol integrase genomic region

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

Comparison of four commercial quantitative HIV-1 assays for viral load monitoring in clinical daily routine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

Real-Time PCR Assays for Hepatitis C Virus (HCV) RNA Quantitation Are Adequate for Clinical Management of Patients with Chronic HCV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

Overestimation and underestimation of hepatitis C virus RNA levels in a widely used real-time polymerase chain reaction-based method

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

HIV-1, HCV and HBV seronegative window reduction by the new Roche cobas TaqScreen MPX test in seroconverting donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.4.369

21 January 2018

Identifiers

DOI

10.1586/14737159.8.4.369

1 reference

18 August 2017

1 reference

PubMed ID

18598219